Lifeward Ltd. (LFWD)
NASDAQ
Real-time Data
01:30 PM
Day's Range
7.2852 wk Range
4.14Overview - LFWD - Lifeward Ltd.
Key Statistics
Valuation
Enterprise Value
18.75M
P/E (Trailing)
‪-0.43‬
P/E (Forward)
‪-8.70‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪0.97‬
Price / Book
‪3.30‬
EV / EBITDA
‪-0.81‬
Profitability
Gross Margin
‪34.20%‬
Profit Margin
‪-141.27%‬
Operating Margin
‪-62.69%‬
Return on Assets
‪-47.26%‬
Return on Equity
‪-225.64%‬
Ownership
Shares Outstanding
2.77M
Float
1.56M
Short % of Shares Outstanding
‪4.31%‬
Held by Insiders
‪47.15%‬
Held by Institutions
‪1.41%‬
Price stats
Beta
‪0.38‬
50-Day Avg
‪7.47‬
200-Day Avg
‪7.16‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪$ 20.00‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LFWD - Lifeward Ltd.
Peers - LFWD - Lifeward Ltd.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - LFWD - Lifeward Ltd.
About
Lifeward Ltd. is a medical technology company specializing in solutions for physical rehabilitation and mobility. The company designs, develops, and markets wearable robotic exoskeletons that provide powered hip and knee motion, enabling individuals with spinal cord injuries to stand, walk, turn, and navigate stairs…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
